IM Cannabis (IMCC) Invested Capital (2021 - 2025)

IM Cannabis' Invested Capital history runs 5 years deep, the most recent figure standing at $10.9 million for Q4 2025.

• On a quarterly basis, Invested Capital fell 2.02% year-over-year to $10.9 million in Q4 2025; TTM through Mar 2026 was $10.9 million, a 2.02% decrease from a year earlier, with the FY2025 full-year figure at $10.9 million, down 3.97% from the prior year.
• Invested Capital fell to $10.9 million in Q4 2025 per IMCC's latest filing, from $11.2 million in the prior quarter.
• Across five years, Invested Capital topped out at $11.2 million in Q4 2024 and bottomed at $3.7 million in Q4 2022.
• The 5-year median for Invested Capital is $8.0 million (2023), against an average of $7.7 million.
• Across the five-year window, Invested Capital slumped 44.99% in 2022 and soared 145.4% in 2023, its largest moves.
• Year by year, Invested Capital stood at $6.8 million in 2021, then slumped by 44.99% to $3.7 million in 2022, then soared by 145.4% to $9.2 million in 2023, then advanced by 21.58% to $11.2 million in 2024, then decreased by 2.02% to $10.9 million in 2025.
• Per Business Quant, the three latest IMCC Invested Capital figures stand at $10.9 million (Q4 2025), $11.2 million (Q4 2024), and $9.2 million (Q4 2023).